Infectious Disease Analyst
Current- Independently lead and support briefings for esteemed clients including the UK Health Security Agency and UNICEF, providing strategic insights and tailored recommendations on emerging health threats and countermeasures
- Deliver in-depth, bespoke epidemiological analyses on mpox for major clients, such as the White House and Bavarian Nordic, focused on the interplay between health determinants, and disease impact, providing actionable.
- Author monthly reports on advancements in vaccine development for infectious diseases, highlighting clinical progress and competition analysis
- Maintain and quality check a database comprising ~3000 vaccine medical countermeasures, including respective clinical trials and regulatory approvals, supervising a team of 2-3 external researchers to ensure data.
- Abstract selected for presentation at IDWeek 2024: ‘The Potential Impact of Vaccination on Clade I Mpox Cases in the Democratic Republic of Congo and Risk of Importation to the United States from International Travel’.